Business Context and Reporting Period
Company: ConAgra Foods, Inc.
Filing Type: Form 8-K (Current Report)
Date: May 24, 2012
Event: Regulation FD Disclosure regarding a presentation by senior management at the Citi 2012 Global Consumer Conference in New York City. The presentation was webcast and primarily consisted of a question-and-answer session.
Key Financial Metrics
The filing does not provide specific historical revenue, profit, cash flow, margin, debt, or liquidity figures for the current or prior periods. It references the use of non-GAAP financial measures (adjusted diluted earnings per share, adjusted return on invested capital, and earnings before income tax, depreciation, and amortization) for evaluating performance but notes that a detailed reconciliation is impracticable due to the unpredictability of items impacting comparability.
Material Changes
No material changes to historical financial results are reported in this filing. The document serves to announce an upcoming management presentation and reiterate previously announced long-term guidance.
Guidance, Outlook, and Risks
Management Guidance
- Fiscal 2012 Q4: Expectation to affirm previously announced guidance of modest diluted earnings per share growth (year-over-year), adjusted for items impacting comparability.
- Long-Term Sales Growth: Approximately 3% annually.
- Long-Term EPS Growth: 6% to 8% annually, excluding items impacting comparability.
- Long-Term Return on Invested Capital (ROIC): 13% to 14%, excluding items impacting comparability.
Risks and Contingencies
Forward-looking statements are subject to uncertainties including:
- Availability and prices of raw materials and inflation effects.
- Effectiveness of product pricing and promotional changes.
- Future economic circumstances and industry conditions.
- Execution of operating and restructuring plans.
- Success of innovation, marketing, and cost-saving initiatives.
- Competitive environment and market conditions.
- Impact of product recalls.
- Integration of acquisitions.
- Access to capital and regulatory factors (including the Patient Protection and Affordable Care Act).
- Timing and amount of common stock repurchases.
Investor Verification Checklist
- Verify the specific content of the presentation slides furnished as Exhibit 99.1 for detailed non-GAAP definitions.
- Confirm the actual Q4 fiscal 2012 results when reported to see if the "modest" EPS growth guidance was met.
- Monitor raw material price trends and inflation data to assess the validity of the long-term margin and ROIC targets.
- Review subsequent filings for updates on the integration of acquisitions and any product recalls mentioned as risk factors.